CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fustinoni, S.
Right arrow Articles by Merlo, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fustinoni, S.
Right arrow Articles by Merlo, D. F.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 2237-2244, September 2005
© 2005 American Association for Cancer Research

Monitoring Low Benzene Exposure: Comparative Evaluation of Urinary Biomarkers, Influence of Cigarette Smoking, and Genetic Polymorphisms

Silvia Fustinoni1, Dario Consonni1, Laura Campo1, Marina Buratti1, Antonio Colombi1, Angela C. Pesatori1, Matteo Bonzini1, Pier A. Bertazzi1, Vito Foà1, Seymour Garte2, Peter B. Farmer3, Leonard S. Levy4, Mauro Pala5, Federico Valerio5, Vincenzo Fontana5, Arianna Desideri5 and Domenico F. Merlo5

1 Department of Occupational and Environmental Health, University of Milan and Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy; 2 School of Public Health, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey; 3 Cancer Biomarkers and Prevention Group, Biocentre and 4 Medical Research Council, Institute for Environmental and Health, University of Leicester, Leicester, United Kingdom; and 5 Environmental Epidemiology and Biostatistics, Department of Cancer Etiology and Epidemiology, National Cancer Research Institute, Genoa, Italy

Requests for reprints: Silvia Fustinoni, Department of Occupational and Environmental Health, University of Milan and Instituti Clinici di Perfezionamento, Via S. Barnaba, 8, 20122 Milan, Italy. Phone: 39-2-503-20116; Fax: 39-2-503-20110. E-mail: silvia.fustinoni{at}unimi.it

Benzene is a human carcinogen and an ubiquitous environmental pollutant. Identification of specific and sensitive biological markers is critical for the definition of exposure to low benzene level and the evaluation of the health risk posed by this exposure. This investigation compared urinary trans,trans-muconic acid (t,t-MA), S-phenylmercapturic acid, and benzene (U-benzene) as biomarkers to assess benzene exposure and evaluated the influence of smoking and the genetic polymorphisms CYP2E1 (RsaI and DraI) and NADPH quinone oxidoreductase-1 on these indices. Gas station attendants, urban policemen, bus drivers, and two groups of controls were studied (415 subjects). Median benzene exposure was 61, 22, 21, 9 and 6 µg/m3, respectively, with higher levels in workers than in controls. U-benzene, but not t,t-MA and S-phenylmercapturic acid, showed an exposure-related increase. All the biomarkers were strongly influenced by cigarette smoking, with values up to 8-fold higher in smokers compared with nonsmokers. Significant correlations of the biomarkers with each other and with urinary cotinine were found. A possible influence of genetic polymorphism of CYP2E1 (RsaI and/or DraI) on t,t-MA and U-benzene in subjects with a variant allele was found. Multiple linear regression analysis correlated the urinary markers with exposure, smoking status, and CYP2E1 (RsaI; R2 up to 0.55 for U-benzene). In conclusion, in the range of investigated benzene levels (<478 µg/m3 or <0.15 ppm), smoking may be regarded as the major source of benzene intake; among the study indices, U-benzene is the marker of choice for biomonitoring low-level occupational and environmental benzene exposure.




This article has been cited by other articles:


Home page
Cancer Res.Home page
V. Bollati, A. Baccarelli, L. Hou, M. Bonzini, S. Fustinoni, D. Cavallo, H.-M. Byun, J. Jiang, B. Marinelli, A. C. Pesatori, et al.
Changes in DNA Methylation Patterns in Subjects Exposed to Low-Dose Benzene
Cancer Res., February 1, 2007; 67(3): 876 - 880.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Kim, R. Vermeulen, S. Waidyanatha, B. A. Johnson, Q. Lan, N. Rothman, M. T. Smith, L. Zhang, G. Li, M. Shen, et al.
Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism
Carcinogenesis, April 1, 2006; 27(4): 772 - 781.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.